title: Imatinib trough levels in chronic myelogenous leukemia: does one dose fit all?
authors.affiliation: Department of Haematology, SA Pathology (IMVS), Adelaide, Australia.
authors.forename: David T
authors.initials: DT
authors.lastname: Yeung
authors.forename: Deborah L
authors.initials: DL
authors.lastname: White
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001549:Benzamides; D015390:Gastric Bypass; D006801:Humans; D000068877:Imatinib Mesylate; D007408:Intestinal Absorption / Q000187:drug effects; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D010879:Piperazines / Q000627:therapeutic use*; D011743:Pyrimidines / Q000627:therapeutic use*
chemical_list: D000970:Antineoplastic Agents; D001549:Benzamides; D010879:Piperazines; D011743:Pyrimidines; D000068877:Imatinib Mesylate